We at Asher Capital specialize in two broad stages of investment: Early Stage and XIR/Growth. We have several managing partners and tend to be active participants with our portfolio companies, helping with team building, business development and strategy.

Our Early Stage practice focuses on investments of a particular kind:

Hatch – incubating and funding ideas created through our partners and ecosystem of entrepreneurs

Seed – funding an idea that is brought to us in its earliest, most fragile stage

Series A – traditional early stage funding for companies that have proven an initial set of assumptions and attracted a core management team

Our XIR/growth practice seeks out companies that would benefit from our management, business building and financial expertise. We focus on companies with greater than $10M in revenue, generally profitable in the $3M-30M EBITDA range, and exhibiting high growth. We’re open to minority and majority recapitalizations for shareholder liquidity and management buy-outs, though we favor businesses with strong entrepreneurial leaders that expect to stay in place after we complete an investment.

*EIR Executive-in-Residence.

*EBITDA is essentially net income with interest, taxes, depreciation, and amortization added back to it, and can be used to analyze and compare profitability between companies and industries because it eliminates the effects of financing and accounting decisions.